How You Might Own a Stake in Moderna's Coronavirus Vaccine Without Even Knowing It
Moderna (NASDAQ: MRNA) has sold a lot of doses of its coronavirus vaccine already. Granted, those sales hinge on regulatory approval or authorization for mRNA-1273. But we're still talking about a lot of money that could be on the way -- over $1.5 billion for 100 million doses in the U.S. alone. Add to that a deal to supply 80 million doses to Europe and an agreement that's potentially on the way with Japan to supply 40 million doses. And that could just be the start.
You could buy shares of Moderna to profit from what could be a phenomenal success for the biotech's COVID-19 vaccine. Then again, you might not have to even do that. Here's how you could own a stake in Moderna's coronavirus vaccine without even knowing it.
Image source: Getty Images.
Source Fool.com
